Open - rolling; next deadline November 6, 2026
Atlas Opportunity Score 99/100
Verified October 7, 2026
Florida Department of Health
Florida has approximately $70 million available through the FY 2026-27 Florida Cancer Innovation Fund for high-impact cancer innovation, clinical and translational work, implementation, technology, screening, nutrition-based prevention and related initiatives. Eligible Florida-based organizations may request up to $2 million; the first rolling application period closes September 25, 2026 at 11:59 PM ET.
Required next actionUse the September 8, 2026 Florida DOH Q&A, FY 2026-27 FOA, and current FCIF portal as controlling guidance. Period 2 is active through November 6, 2026 and Period 3 runs November 7 through December 18, 2026. Confirm statutory eligibility, select the correct grant category, prepare the required work plan with measurable deliverables and success metrics, and submit through the portal during the applicable rolling period. Equipment above $5,000 requires additional Department review, and any subcontract requires pre-approval and narrative justification.
Open — LOI-qualified applicants only
Atlas Opportunity Score 96/100
Verified September 29, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
CPRIT's FY 2027 Cycle 2 Texas Regional Excellence in Cancer Award offers up to $6 million over five years. The mandatory September 4, 2026 at 5:00 PM Central Time Letter of Intent gate has closed; only institutions that timely submitted an LOI and received CPRIT approval may proceed to the September 16-November 18, 2026 full application window.
Required next actionThe September 4, 2026 at 5:00 PM CT mandatory LOI deadline has passed. Do not initiate a new TREC pursuit. Proceed only if the institution timely submitted its LOI and CPRIT approved it. Qualified applicants should now prepare the full application for the September 16, 2026 at 7:00 AM CT opening and November 18, 2026 at 5:00 PM CT deadline, preserving the approved institutional theme, PI, shared-resource strategy, budget and required research-capacity elements.
Active
Atlas Opportunity Score 94/100
35 days leftVerified September 27, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
Opportunity Overview The Cancer Prevention and Research Institute of Texas (CPRIT) lists the Core Facility Support Award, FY 2027 Cycle 2, as an open Academic Research funding opportunity. The award supports development or improvement of shared core facilities that provide valuable research services and capabilities to scientifically meritorious cancer-research projects in Texas. Funding and Application […]
Required next actionComplete the current CPRIT application requirements for the core facility, verify Grants Management Platform access and the institutional submission limit, and submit by November 18, 2026 at 5:00 PM CT.
Open — LOI-qualified applicants only
Atlas Opportunity Score 93/100
Verified September 29, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
CPRIT's FY 2027 Cycle 2 Texas Regional Training Award offers up to $2 million over five years for eligible regional institutions. The mandatory September 4, 2026 at 5:00 PM Central Time Letter of Intent gate has closed; only institutions that timely submitted an LOI and received CPRIT approval may proceed to the September 16-November 18, 2026 full application window.
Required next actionThe September 4, 2026 at 5:00 PM CT mandatory LOI deadline has passed. Do not initiate a new TRTA pursuit. Proceed only if the institution timely submitted its LOI and CPRIT approved it. Qualified applicants should now prepare the full application for the September 16, 2026 at 7:00 AM CT opening and November 18, 2026 at 5:00 PM CT deadline, preserving the approved training theme, PI, trainee structure, mentoring plan, budget and required regional cancer-workforce elements.
Active
Atlas Opportunity Score 93/100
35 days leftVerified September 27, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
Opportunity Overview The Cancer Prevention and Research Institute of Texas has opened the FY 2027 Cycle 2 Clinical Investigator Award to strengthen the pipeline of clinician-scientists conducting patient-oriented cancer research in Texas. The mechanism is designed to protect research time, deepen clinical-research skills, expand translational collaborations, and develop the next generation of clinical investigators. Funding […]
Required next actionComplete the current CPRIT application requirements, verify Grants Management Platform access, satisfy the institution-specific submission requirements, and submit by November 18, 2026 at 5:00 PM CT.
Active
Atlas Opportunity Score 93/100
35 days leftVerified September 27, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
CPRIT is offering up to $4 million over five years for FY 2027 Cycle 2 Research Training Awards that build integrated Texas cancer-research workforce programs for predoctoral trainees, postdoctoral fellows and clinical fellows. Applications open September 16 and close November 18, 2026.
Required next actionComplete the current CPRIT application requirements for the integrated research-training program, verify Grants Management Platform access and institutional eligibility, and submit by November 18, 2026 at 5:00 PM CT.
Open - application receipt active through May 20, 2027
Atlas Opportunity Score 92/100
Verified September 27, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
<p>CPRIT's FY 2027 Cycle 2 Recruitment or Retention of Clinical Trialists Award provides up to $2 million to $3 million over five years, depending on faculty rank, to build cancer clinical research leadership in rural and underserved Texas communities. Applications open September 16, 2026 and close May 20, 2027 with continuous award notification.</p>
Required next actionReview current official CPRIT materials; the FY27 Cycle 2 receipt window is open.
Active — current review cycle closes October 20, 2026
Atlas Opportunity Score 92/100
Verified October 1, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
CPRIT's FY 2027 Recruitment of Established Investigators program is open to Texas public and private institutions of higher education, including academic health institutions, seeking to recruit distinguished senior cancer researchers. Awards are up to $4 million over five years. The current FY27 review cycle closes October 20, 2026 at 11:59 PM Central Time, with later rolling cycles continuing through June 21, 2027 subject to available funding.
Required next actionIdentify a qualifying senior cancer investigator and institutional nominator; confirm current RFA/IFA eligibility; assemble investigator and institutional PDF materials; complete the nominator and Authorized Signing Official workflow; and submit by October 20, 2026 at 11:59 PM CT for the current review cycle. If missed, verify funding remains available before using a later FY27 recruitment cycle.
Open — FY2026-27 application materials and intake posted
Atlas Opportunity Score 91/100
Verified October 7, 2026
Florida Department of Health
Florida's FY2026-27 Biomedical Research Advisory Council FOA funds cancer, pediatric-cancer, and tobacco-related biomedical research through the Bankhead-Coley, James and Esther King, and Live Like Bella programs. The required Letter of Intent closed September 2, 2026 at noon ET; the application stage is now open only to applicants with a timely LOI, with full applications due October 21, 2026 at noon ET.
Required next actionOnly applicants that submitted the required Letter of Intent by September 2, 2026 at noon ET remain eligible for this cycle. Those applicants should complete the appropriate BRAC application in PeerNet, confirm the selected program and grant mechanism, finalize the required work plan, evaluation plan, budget and supporting materials, and submit by October 21, 2026 at noon ET.
Active — current review cycle closes October 20, 2026
Atlas Opportunity Score 91/100
Verified October 1, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
CPRIT's FY 2027 Recruitment of Rising Stars program is open for Texas academic institutions recruiting outstanding mid-stage cancer investigators. Awards are up to $3 million over five years. The current FY27 review cycle closes October 20, 2026 at 11:59 PM Central Time, with later rolling cycles continuing through June 21, 2027 subject to available funding.
Required next actionIdentify a qualifying mid-stage cancer investigator and institutional nominator; confirm current RFA/IFA eligibility; assemble candidate and institutional PDF materials; complete the nominator and Authorized Signing Official workflow; and submit by October 20, 2026 at 11:59 PM CT for the current review cycle. If missed, verify funding remains available before using a later FY27 recruitment cycle.
Open — FY27 Cycle 2 application receipt active through November 18, 2026
Atlas Opportunity Score 91/100
Verified September 29, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
CPRIT's FY 2027 Cycle 2 Clinical Trials Network Award provides up to $500,000 per year for up to five years to Texas lead institutions building networks that expand access to phase 2 and selected phase 3 cancer therapeutic trials. Applications open September 16, 2026 at 7:00 AM Central Time and close November 18, 2026 at 5:00 PM Central Time. A mandatory available-funds requirement equal to one-half of CPRIT funding applies before disbursement.
Required next actionReview the current CPRIT CTNA RFA and application materials, confirm lead-institution and network eligibility, define the participating cancer-care network and clinical-trials infrastructure, complete the required scientific and administrative materials, and submit during the FY2027 Cycle 2 application-receipt window ending November 18, 2026.
Open - application receipt active through November 18, 2026 at 5:00 PM CT.
Atlas Opportunity Score 90/100
35 days leftVerified September 27, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
<p>CPRIT's FY 2027 Cycle 2 Catalyst Pilot Research Award provides up to $250,000 over two years for innovative cancer research and gap funding. Applications open September 16 and close November 18, 2026.</p>
Required next actionConfirm the Texas-based applicant and PI satisfy RFA R-27.2-CPRA, resolve the institution's internal selection process because CPRIT limits submissions to 8 from an academic research institution and 1 from each nonacademic institution, verify organization and user access in the CPRIT Grants Management Platform, finalize the cancer-research hypothesis, aims, milestones and two-year budget, and submit by November 18, 2026 at 5:00 PM CT.
Active — current review cycle closes October 20, 2026
Atlas Opportunity Score 90/100
Verified October 1, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
CPRIT's FY 2027 Recruitment of First-Time, Tenure-Track Faculty Members program is open for Texas academic institutions recruiting promising emerging cancer investigators into their first faculty appointments. Awards are up to $2 million over five years. The current FY27 review cycle closes October 20, 2026 at 11:59 PM Central Time, with later rolling cycles continuing through June 21, 2027 subject to available funding.
Required next actionConfirm the candidate fits the first-time tenure-track mechanism; designate the institutional nominator; verify current RFA/IFA requirements; assemble candidate and institutional PDF materials; complete the nominator and Authorized Signing Official workflow; and submit by October 20, 2026 at 11:59 PM CT for the current review cycle. If missed, verify funding remains available before using a later FY27 recruitment cycle.
Draft / Verification Hold - 2026 deadline, award parameters, and complete current application requirements are not yet authoritatively published
Atlas Opportunity Score 84/100
Verified September 23, 2026
Lexington Cancer Foundation
Required next actionConfirm the authoritative 2026 submission deadline and time zone directly from Lexington Cancer Foundation; verify that the currently linked four-page application remains the controlling 2026 form despite legacy footer contact information; confirm any 2026 award limits, match or cost-share, allowable and prohibited costs, required attachments, and amendments. Then identify a specific Kentucky cancer-serving applicant and clear verified Contact, Email_Opt_Out, permanent-bounce, CRM/Deal/Atlas_Email_Queue, authoritative send-history, and cross-lane deduplication gates before any ORIGINAL outreach.
Closed — 2026 proposal cycle ended October 1, 2026
Atlas Opportunity Score 78/100
Verified October 4, 2026
Breast Cancer Research Foundation of Alabama (BCRFA)
The Breast Cancer Research Foundation of Alabama is accepting 2026 Alabama breast cancer research proposals through October 1, 2026. Awards include $100,000 two year research grants and $25,000 Catalyst Awards for eligible early investigators.
Required next actionTreat the 2026 cycle as closed. Preserve the record for intelligence and monitor BCRFA for the next research-grant cycle before preparing a new application.
Closed
Atlas Opportunity Score 76/100
Verified September 19, 2026
Illinois Department of Public Health
Illinois Department of Public Health competitive grant supporting institution-based childhood cancer research in Illinois. One award of $38,792.05 is anticipated. Applications are due September 18, 2026 at 4:30 p.m.
Required next actionClosed as of September 18, 2026. Do not initiate new applicant outreach or submission activity. Preserve the record for historical intelligence and monitor only for a formal reopening, amendment, or successor Illinois childhood-cancer research opportunity.
Active
Atlas Opportunity Score 65/100
Verified September 10, 2026
National Cancer Institute (NCI)
NCI Phase I SBIR contract offering $300,000 for high-risk, high-reward technologies in pediatric and rare cancers. Proposals are due September 21, 2026 at 5:00 PM ET. N9+ fit is conditional on a defensible cancer-specific R&D objective.
Required next actionRun a rapid cancer-specific technical screen before any direct pursuit. Advance only if N9+ or another Dr. Miltie capability can support a genuinely innovative pediatric- or rare-cancer research, detection, treatment, or care objective and all SBIR contract eligibility, registration, personnel, and submission requirements can be satisfied.
Closed — deadline passed
Verified September 18, 2026
Michigan Ovarian Cancer Alliance
Opportunity Overview The Michigan Ovarian Cancer Alliance (MIOCA) is accepting applications for the 2026 Geri Fournier Ovarian Cancer Research Grant. The program supports innovative ovarian cancer research conducted in Michigan by Michigan-based researchers. Proposals may be stand-alone projects or part of larger research efforts involving ovarian, peritoneal, or fallopian tube cancers. Funding and Deadline Individual […]
Required next actionClosed. The authoritative MIOCA announcement set the 2026 application deadline as September 18, 2026, which has passed. Do not begin or continue new applicant outreach, CRM production, or package execution for this cycle. Preserve the record for historical reference and monitor only for a future MIOCA research-grant cycle.
